Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sutter

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Emerging Infectious Diseases|November 19, 2016
Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016George Shirreff, Mufti Zubair Wadood, Rui Gama Vaz, et al.
Bulletin of the World Health Organization|May 2, 2002
Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccineKathryn A Kohler, Kaushik Banerjee, W Gary Hlady, et al.
Nano Letters|June 1, 2013
In situ liquid cell electron microscopy of the solution growth of Au-Pd core-shell nanostructuresK L Jungjohann, S Bliznakov, P W Sutter, et al.
Journal of Epidemiology and Global Health|July 14, 2015
Achieving high seroprevalence against polioviruses in Sri Lanka--results from a serological survey, 2014Deepa Gamage, Paba Palihawadana, Ondrej Mach, et al.
MMWR. Morbidity and Mortality Weekly Report|June 19, 2015
Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015Ousmane M Diop, Cara C Burns, Roland W Sutter, et al.
Annals of the New York Academy of Sciences|May 31, 1995
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccinationR W Sutter, M A Pallansch, L A Sawyer, et al.
Archives of Pediatrics & Adolescent Medicine|May 1, 1994
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated diseaseD R Prevots, R W Sutter, P M Strebel, et al.
The New England Journal of Medicine|February 23, 1995
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitisP M Strebel, N Ion-Nedelcu, A L Baughman, et al.
Emerging Infectious Diseases|September 26, 2018
Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014-2017Nicholas C Grassly, Mufti Zubair Wadood, Rana M Safdar, et al.
MMWR. Morbidity and Mortality Weekly Report|August 5, 2016
Update on Vaccine-Derived Polioviruses - Worldwide, January 2015-May 2016Jaume Jorba, Ousmane M Diop, Jane Iber, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Emerging Infectious Diseases|November 19, 2016
Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016George Shirreff, Mufti Zubair Wadood, Rui Gama Vaz, et al.
Bulletin of the World Health Organization|May 2, 2002
Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccineKathryn A Kohler, Kaushik Banerjee, W Gary Hlady, et al.
Nano Letters|June 1, 2013
In situ liquid cell electron microscopy of the solution growth of Au-Pd core-shell nanostructuresK L Jungjohann, S Bliznakov, P W Sutter, et al.
Journal of Epidemiology and Global Health|July 14, 2015
Achieving high seroprevalence against polioviruses in Sri Lanka--results from a serological survey, 2014Deepa Gamage, Paba Palihawadana, Ondrej Mach, et al.
MMWR. Morbidity and Mortality Weekly Report|June 19, 2015
Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015Ousmane M Diop, Cara C Burns, Roland W Sutter, et al.
Annals of the New York Academy of Sciences|May 31, 1995
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccinationR W Sutter, M A Pallansch, L A Sawyer, et al.
Archives of Pediatrics & Adolescent Medicine|May 1, 1994
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated diseaseD R Prevots, R W Sutter, P M Strebel, et al.
The New England Journal of Medicine|February 23, 1995
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitisP M Strebel, N Ion-Nedelcu, A L Baughman, et al.
Emerging Infectious Diseases|September 26, 2018
Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014-2017Nicholas C Grassly, Mufti Zubair Wadood, Rana M Safdar, et al.
MMWR. Morbidity and Mortality Weekly Report|August 5, 2016
Update on Vaccine-Derived Polioviruses - Worldwide, January 2015-May 2016Jaume Jorba, Ousmane M Diop, Jane Iber, et al.
Pageof 19